Back to Ovarian Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT00757185

NCT00757185
Completed Early Phase 1

Who may be able to join

Who might be able to join this trial:

  • Women between the ages of 18 and 35 who are obese, either with or without a condition called PCOS (Polycystic Ovary Syndrome, a hormonal condition affecting the ovaries)

Who may not be able to join:

  • Women who have certain health conditions that would make it unsafe for them to take hormones (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Early Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Trial details

Status
Completed
Phase
Early Phase 1
Sponsor
Yale University
Registry
clinicaltrials_gov
Start date
1 February 2008
Est. completion
1 April 2012

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Skin blood flow and cutaneous vascular conductance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov